Premature baby oral feeding plate
Related entities
Findings (50)
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 4-fold increased odds of chronic feeding problems and 2.4-fold increased odds of chronic breathing problems at 18-22 month follow-up.
Effect: decline; OR 4.06; CI: 95% CI 3.12-5.28
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10
None
declineGastrostomy tube placement in ELBW infants was associated with a 3-fold increased odds of neurodevelopmental impairment at 18-22 month follow-up, including significantly higher rates of cerebral palsy
Effect: decline; OR 3.19; CI: 95% CI 2.49-4.10